1. Home
  2. PAVM vs SNGX Comparison

PAVM vs SNGX Comparison

Compare PAVM & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAVM
  • SNGX
  • Stock Information
  • Founded
  • PAVM 2014
  • SNGX 1987
  • Country
  • PAVM United States
  • SNGX United States
  • Employees
  • PAVM N/A
  • SNGX N/A
  • Industry
  • PAVM Medical/Dental Instruments
  • SNGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PAVM Health Care
  • SNGX Health Care
  • Exchange
  • PAVM Nasdaq
  • SNGX Nasdaq
  • Market Cap
  • PAVM 7.2M
  • SNGX 7.4M
  • IPO Year
  • PAVM 2016
  • SNGX 1987
  • Fundamental
  • Price
  • PAVM $0.61
  • SNGX $2.32
  • Analyst Decision
  • PAVM Strong Buy
  • SNGX
  • Analyst Count
  • PAVM 1
  • SNGX 0
  • Target Price
  • PAVM $19.00
  • SNGX N/A
  • AVG Volume (30 Days)
  • PAVM 121.2K
  • SNGX 620.7K
  • Earning Date
  • PAVM 03-25-2025
  • SNGX 03-14-2025
  • Dividend Yield
  • PAVM N/A
  • SNGX N/A
  • EPS Growth
  • PAVM N/A
  • SNGX N/A
  • EPS
  • PAVM 0.53
  • SNGX N/A
  • Revenue
  • PAVM $4,034,000.00
  • SNGX $364,183.00
  • Revenue This Year
  • PAVM $52.90
  • SNGX N/A
  • Revenue Next Year
  • PAVM $248.84
  • SNGX $76.64
  • P/E Ratio
  • PAVM $1.17
  • SNGX N/A
  • Revenue Growth
  • PAVM 166.27
  • SNGX N/A
  • 52 Week Low
  • PAVM $0.57
  • SNGX $0.32
  • 52 Week High
  • PAVM $3.50
  • SNGX $14.83
  • Technical
  • Relative Strength Index (RSI)
  • PAVM 39.43
  • SNGX 36.12
  • Support Level
  • PAVM $0.62
  • SNGX $2.23
  • Resistance Level
  • PAVM $0.66
  • SNGX $2.39
  • Average True Range (ATR)
  • PAVM 0.05
  • SNGX 0.17
  • MACD
  • PAVM 0.01
  • SNGX 0.01
  • Stochastic Oscillator
  • PAVM 33.52
  • SNGX 22.12

About PAVM PAVmed Inc.

PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The Company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Share on Social Networks: